share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K:重大事件
美股sec公告 ·  05/16 12:16
Moomoo AI 已提取核心信息
On May 14, 2024, Assure Holdings Corp. reconvened its previously adjourned special meeting of stockholders, where a significant resolution was passed. Shareholders approved an amendment to the Company's Articles of Incorporation, which will increase the authorized shares of common stock from 9,000,000 to 250,000,000. The approval was achieved with 5,226,969 votes in favor, 194,592 against, and 5,901 abstentions. This move is part of Assure's strategy to merge with Danam Health and maintain its NASDAQ listing. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. In addition, Assure issued a press release on May 16, 2024, to announce the stockholder approval of the increase in authorized shares. The press release also serves as a reminder of the proposed transactions between Assure...Show More
On May 14, 2024, Assure Holdings Corp. reconvened its previously adjourned special meeting of stockholders, where a significant resolution was passed. Shareholders approved an amendment to the Company's Articles of Incorporation, which will increase the authorized shares of common stock from 9,000,000 to 250,000,000. The approval was achieved with 5,226,969 votes in favor, 194,592 against, and 5,901 abstentions. This move is part of Assure's strategy to merge with Danam Health and maintain its NASDAQ listing. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. In addition, Assure issued a press release on May 16, 2024, to announce the stockholder approval of the increase in authorized shares. The press release also serves as a reminder of the proposed transactions between Assure and Danam Health Inc., for which relevant materials have been filed with the SEC, including a registration statement on Form S-4 containing a prospectus and a proxy statement. The documents are essential for investors and security holders, providing important information about the proposed transactions. The Company's CEO, John Farlinger, expressed gratitude to the stockholders for their support, which enables the management to execute their strategic plans.
2024年5月14日,Assure Holdings Corp. 重新召开了先前休会的股东特别会议,会上通过了一项重要决议。股东批准了公司章程的修正案,该修正案将把普通股的法定股数从9,000,000股增加到2.5亿股。以5,226,969张赞成票、194,592票反对和5,901张弃权票获得批准。此举是Assure与达南健康合并并维持其在纳斯达克上市的战略的一部分。该公司计划立即提交修正案,以实现授权普通股的增加。此外,Assure于2024年5月16日发布了一份新闻稿,宣布股东批准增加授权股份。该新闻稿还提醒人们注意Assure和Danam Health Inc. 之间的拟议交易,相关材料已向美国证券交易委员会提交,包括一份包含招股说明书和委托书的S-4表格注册声明。这些文件对投资者和证券持有人至关重要,提供了有关拟议交易的重要信息。公司首席执行官约翰·法林格对股东的支持表示感谢,这使管理层能够执行其战略计划。
2024年5月14日,Assure Holdings Corp. 重新召开了先前休会的股东特别会议,会上通过了一项重要决议。股东批准了公司章程的修正案,该修正案将把普通股的法定股数从9,000,000股增加到2.5亿股。以5,226,969张赞成票、194,592票反对和5,901张弃权票获得批准。此举是Assure与达南健康合并并维持其在纳斯达克上市的战略的一部分。该公司计划立即提交修正案,以实现授权普通股的增加。此外,Assure于2024年5月16日发布了一份新闻稿,宣布股东批准增加授权股份。该新闻稿还提醒人们注意Assure和Danam Health Inc. 之间的拟议交易,相关材料已向美国证券交易委员会提交,包括一份包含招股说明书和委托书的S-4表格注册声明。这些文件对投资者和证券持有人至关重要,提供了有关拟议交易的重要信息。公司首席执行官约翰·法林格对股东的支持表示感谢,这使管理层能够执行其战略计划。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息